Sideroblastic anemia secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Nazia Fuad (talk | contribs) |
Nazia Fuad (talk | contribs) |
||
Line 15: | Line 15: | ||
* Regular liver function tests to assess for liver disease | * Regular liver function tests to assess for liver disease | ||
* Regular CBC in patients with MDS | * Regular CBC in patients with MDS | ||
* Cardiac monitoring | |||
==References== | ==References== |
Revision as of 13:13, 10 August 2018
Sideroblastic anemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sideroblastic anemia secondary prevention On the Web |
American Roentgen Ray Society Images of Sideroblastic anemia secondary prevention |
Risk calculators and risk factors for Sideroblastic anemia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Secondary Prevention
Effective measures for the secondary prevention of sideroblastic anemia include:
- Iron chelators
- Phlebotomy
- Regular liver function tests to assess for liver disease
- Regular CBC in patients with MDS
- Cardiac monitoring